4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Curanex Pharmaceuticals Inc (CURX) operates in the Biotechnology industry and is headquartered in Jericho, United States. Its market capitalization is roughly $6 million. In the fiscal year ended 2025-12-31, CURX reported $0M in revenue and ($4M) in net income.
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Gross Profit | — | — | $0M | $0M |
| Operating Income (EBIT) | ($4M) | ($0M) | $0M | $0M |
| Net Income | ($4M) | ($0M) | $0M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($3M) | ($3M) | ($1M) | ($0M) | ($0M) |
| Net Income | ($3M) | ($3M) | ($1M) | ($0M) | ($0M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $12M | $0M | $0M | $0M |
| Total Liabilities | $0M | $0M | $0M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CURX viewer.
About TickerBase · Data methodology & sources